- Previous Rank-
- Revenues ($M)2,234
- Revenue Percent Change44%
- Profits ($M)657
- Profits Percent Change159.8%
- Market Value (as of March 31, 2015)35,032
Looking for leads, investment insights, or competitive intelligence?Buy Now
Company Info
| CEO | David L. Hallal |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| HQ Location | Cheshire, CT |
| Website | http://www.alexion.com |
| Years on List | - |
Key Financials (last fiscal year)
| $ millions | % change | |
|---|---|---|
| Revenues ($M) | 2,234 | 44% |
| Profits ($M) | 657 | 159.8% |
| Total Stockholder Equity | 3,302 | - |
| Employees | 2,273 | - |
| Market Value (as of March 31, 2015) | 35,032 | - |
Profit Ratios
| Profit as % of Revenues | 29.4% |
| Profits as % of Assets | 15.6% |
| Profits as % of Stockholder Equity | 19.9% |
Earnings Per Share (last fiscal year)
| Earnings Per Share ($) | 3.26 |
| EPS % Change (from 2013) | 156.7% |
| EPS % Change (5 year annual rate) | 14.9% |
| EPS % Change (10 year annual rate) | - |
Total Return
| Total Return to Investors (2014) | 39.2% |
| Total Return to Investors (5 year, annualized) | 49.9% |
| Total Return to Investors (10 year, annualized) | 40.2% |
